- psychiatry https://www.mcgill.ca/psychiatry
- med_fac http://www.mcgill.ca/channels
- In the Headlines
- mni https://www.mcgill.ca/channels-contribute
- Medicine Research
- medicine_research https://www.mcgill.ca/medicine
- press_releases https://www.mcgill.ca/newsroom
- External
- Faculty
- Staff
- Students
The Liberals must find their sweet spot
Scientist at work: From the negative 71st parallel
April is Parkinson’s Disease Awareness Month
What is Parkinson’s Disease?
Parkinson’s disease is a neurological condition related to the death of specific brain cells that produce dopamine, a chemical needed for brain cells to control muscular movement. In Parkinson’s disease, dopamine-producing cells stop functioning for reasons still unknown.
HIV Self-testing:key to controlling the global epidemic
“Thirty years into the HIV* epidemic, there is no vaccine in sight. Treatment as a prevention strategy has been known to work, but uptake of HIV screening seems to be limited by a societal problem: HIV stigma and perceived discrimination,” says Dr. Nitika Pant Pai, who is the first and corresponding author of the study, a clinical researcher at the RI-MUHC and assistant professor in the Department of Medicine at McGill University.
Rewind: Cassettes are cool again
Hacking the world
Researchers say fame lasts a lot longer than 15 minutes
Music as medicine has huge potential, study suggests
Risky treatment gives doctor his life back
Study finds true fame not fleeting
Hult Prize: Ending hunger, one cricket at a time

Only fifteen minutes of fame?
True fame isn’t fleeting. That’s what a team of researchers led by Eran Shor from McGill University’s Dept. of Sociology and Arnout van de Rijt of Stony Brook University conclude. They studied all the names mentioned in over 2,000 English-language newspapers from the U.S., Canada and the U.K. over a period of several decades. What they found was that, contrary to popular belief (and scholarly research up to now), the people who become truly famous stay famous for decades, and that this is the case whatever field they are in, including sports and politics.
Major advance in understanding risky but effective Multiple Sclerosis treatment
Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease
A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation (BMT) has positive results in patients with particularly aggressive forms of MS. The transplantation treatment, which is performed as part of a clinical trial and carries potentially serious risks, virtually stops all new relapsing activity as observed upon clinical examination and brain MRI scans. The study reveals how th

